Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype
Inflammatory cytokines initiate and sustain the perpetuation of processes leading to chronic inflammatory conditions such as inflammatory bowel diseases (IBD). The nature of the trigger causing an inflammatory reaction decides whether type 1, type 17, or type 2 immune responses, typically characteri...
Main Authors: | Miguel Gonzalez Acera, Jay V. Patankar, Leonard Diemand, Britta Siegmund, Markus F. Neurath, Stefan Wirtz, Christoph Becker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.664045/full |
Similar Items
-
Dynamic, Transient, and Robust Increase in the Innervation of the Inflamed Mucosa in Inflammatory Bowel Diseases
by: Miguel Gonzalez Acera, et al.
Published: (2021-08-01) -
Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases
by: Jay V. Patankar, et al.
Published: (2023-06-01) -
CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis
by: Le Kang, et al.
Published: (2021-02-01) -
Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis
by: Aylin Lindemann, et al.
Published: (2023-06-01) -
Endoscopic features of non-IBD colitis
by: Flavia Pigò, et al.
Published: (2023-12-01)